Immunic, INC. (IMUX) — 8-K Filings

All 8-K filings from Immunic, INC.. Browse 27 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (27)

8-K Filing — Apr 1, 2026
Immunic Appoints New CMO, Dr. Feldmann — Mar 31, 2026 Risk: medium
On March 31, 2026, IMMUNIC, INC. filed an 8-K report detailing the departure of Dr. Andreas Marneropoulos as Chief Medical Officer, effective March 27, 2026. Th
IMMUNIC, INC. Files 8-K on Financials — Nov 13, 2025 Risk: low
On November 13, 2025, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as f
IMMUNIC, INC. Files 8-K Report — Sep 25, 2025 Risk: low
On September 25, 2025, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific fina
IMMUNIC, INC. Files 8-K for Operations and Financial Condition — Aug 7, 2025 Risk: low
On August 7, 2025, IMMUNIC, INC. (IMUX) reported its financial results and condition. The filing does not contain specific financial figures or operational deta
Immunic, Inc. Announces Board Changes and Compensation Updates — Jul 11, 2025 Risk: medium
On July 7, 2025, IMMUNIC, INC. reported a change in its board of directors, with the departure of Dr. Andreas M. Marneros and the appointment of Dr. Paul W. Smi
IMMUNIC Faces Nasdaq Delisting Over Bid Price — Jun 27, 2025 Risk: high
On June 27, 2025, IMMUNIC, INC. filed an 8-K report indicating a potential delisting from the Nasdaq Capital Market. The company received a deficiency letter fr
IMMUNIC, INC. Files 8-K: Director Changes & Officer Compensation Updates — Jun 4, 2025 Risk: medium
On June 4, 2025, IMMUNIC, INC. filed an 8-K report detailing several key events. The company announced the departure of a director, the election of new director
IMMUNIC, INC. Files 8-K: Material Agreement — May 30, 2025 Risk: medium
On May 28, 2025, IMMUNIC, INC. entered into a material definitive agreement. The filing also includes Regulation FD disclosures and financial statements and exh
IMMUNIC, INC. Files 8-K Report — May 28, 2025 Risk: low
On May 28, 2025, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial
8-K Filing — Apr 30, 2025
IMMUNIC, INC. Files 8-K with Material Agreements and Equity Sales — Apr 9, 2025 Risk: medium
On April 9, 2025, IMMUNIC, INC. filed an 8-K report detailing several key events. The company entered into a material definitive agreement and reported unregist
IMMUNIC, INC. Files 8-K Report — Feb 20, 2025 Risk: low
On February 20, 2025, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or ot
Immunic, Inc. Files Form 8-K — Jan 13, 2025 Risk: medium
On January 13, 2025, Immunic, Inc. reported an event under Item 8.01 of its Form 8-K. The filing does not contain specific details about the nature of the event
Dr. Daniel S. von Hoff Joins IMMUNIC Board — Dec 18, 2024 Risk: low
On December 13, 2024, IMMUNIC, INC. filed an 8-K report detailing the election of Dr. Daniel S. von Hoff as a Class II director, effective immediately. Dr. von
IMMUNIC, INC. Files 8-K: Operations, Financials, and Exhibits — Nov 7, 2024 Risk: medium
On November 7, 2024, IMMUNIC, INC. filed an 8-K report detailing significant corporate events. The filing includes information on the company's results of opera
IMMUNIC, INC. Files 8-K Report — Oct 22, 2024 Risk: low
On October 22, 2024, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or oth
IMMUNIC, INC. Files 8-K Report — Sep 10, 2024 Risk: low
On September 10, 2024, IMMUNIC, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific fina
IMMUNIC, INC. Files 8-K for Material Definitive Agreement — Sep 3, 2024 Risk: medium
On August 29, 2024, IMMUNIC, INC. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company, incorp
IMMUNIC, INC. Files 8-K: Operations & Financial Update — Aug 8, 2024 Risk: medium
On August 8, 2024, IMMUNIC, INC. filed an 8-K report detailing the results of operations and financial condition, along with other events and financial statemen
IMMUNIC, INC. Files 8-K: Board Changes and Executive Compensation Updates — Jul 24, 2024 Risk: medium
On July 21, 2024, IMMUNIC, INC. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the election of
IMMUNIC, INC. Files 8-K: Board and Compensation Updates — Jul 9, 2024 Risk: medium
On July 9, 2024, IMMUNIC, INC. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing includes the
IMMUNIC, INC. Stockholders Elect Directors, Ratify Auditors — Jun 13, 2024 Risk: low
On June 11, 2024, IMMUNIC, INC. filed an 8-K to report the results of its Annual Meeting of Stockholders held on June 11, 2024. The company announced that its s
IMMUNIC, INC. Files 8-K Report — May 8, 2024 Risk: medium
On May 8, 2024, IMMUNIC, INC. filed an 8-K report detailing significant corporate events. The filing includes information on the company's results of operations
IMMUNIC, INC. Reports Annual Meeting Results and Corporate Changes — Mar 8, 2024 Risk: low
On March 4, 2024, IMMUNIC, INC. filed an 8-K report detailing several key events. The company announced the results of its annual meeting of stockholders, inclu
IMMUNIC Files 8-K on Financial Condition and Operations — Feb 22, 2024 Risk: low
IMMUNIC, INC. filed an 8-K on February 22, 2024, reporting on its results of operations and financial condition, as well as other events and financial statement
IMMUNIC (IMUX) Enters Material Agreement, Unregistered Equity Sale — Jan 5, 2024
IMMUNIC, INC. (IMUX) entered into a material definitive agreement and conducted unregistered sales of equity securities on January 4, 2024. This likely involves

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX